- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Lithium heparin anticoagulant with CAS 9045-22-1 for blood gas analysis |
| Catalog No. | ATR-SPS-0079 |
| Description | Lithium heparin is a lithium salt of sulfated mucopolysaccharide that delivers fast, dependable anticoagulation for blood gas testing. By binding to antithrombin III, it sharply increases the inhibition of thrombin and keeps samples stable throughout analysis. Comparative testing shows it preserves the stability of biochemical markers such as HBD, LDH and total bile acids, while exerting minimal influence on key blood gas parameters including pH, PO2 and PCO2. |
| Intended Use | Anticoagulation of blood specimens intended for blood gas analysis and related biochemical testing. |
| Principle / Technology | Binds to antithrombin III (AT-III) and significantly enhances AT-III-mediated inhibition of thrombin, preventing clot formation. |
| Sample Type | Whole blood, plasma |
| Storage Conditions | Store sealed in a cool, dry place; prepared 1 g/L saline solutions should be kept at 0-4°C and used within 7 days |
| Shelf Life | 3 years |
| Product Form | Powder |
| Key Features | Rapid and effective anticoagulation; negligible impact on pH, PO2 and PCO2; odorless and hygroscopic; maintains stability of HBD, LDH and TBA in samples |
| Appearance | White to off-white powder |
| Solubility | Readily soluble in water |
| CAS Number | 9045-22-1 |
| Potency | ≥150 IU/mg |
| Physical Properties | Odorless; readily water-soluble; hygroscopic |
| Working Solution | Typically used as a 1 g/L solution in physiological saline; store at 0-4°C and use within 7 days of preparation |
For research use only, not for clinical use.
|
There is no product in your cart. |